SUSAN WALLACE: Open Payments
NPI 1093826497 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 24 payments from 12 companies in 2025. Trend: 2023 $886 · 2024 $877 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $84 |
| Lilly USA, LLC | 3 | $52 |
| PFIZER INC. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| ABBVIE INC. | 2 | $36 |
| Exact Sciences Corporation | 1 | $27 |
| Corcept Therapeutics | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 3 | $15 |
| Gilead Sciences, Inc. | 1 | $14 |
| SANOFI-AVENTIS U.S. LLC | 1 | $14 |
Products named: MOUNJARO, REXULTI, NURTEC ODT, Wegovy, Cologuard Collection Kit, Korlym, UBRELVY, Ozempic.
Industry payments across NE — which companies pay providers there.
